ERIS Lifesciences consolidated net profit rises 19.05% in the December 2025 quarter
Sales rise 10.91% to Rs 800.89 crore
Net profit of ERIS Lifesciences rose 19.05% to Rs 99.72 crore in the quarter ended December 2025 as against Rs 83.76 crore during the previous quarter ended December 2024. Sales rose 10.91% to Rs 800.89 crore in the quarter ended December 2025 as against Rs 722.12 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales800.89722.12 11 OPM %35.1634.66 -PBDT232.93197.36 18 PBT162.59116.36 40 NP99.7283.76 19Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 13 2026 | 3:37 PM IST